BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 4
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11988)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.
Item 
Count 
PDF848
WORD373
HTML8262
Tables (1-3)209
 Sum=9692
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1171
Download1125
 Sum=2296
Apr 27, 2014 (publication date) through Dec 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014; 6(4): 160-168 [PMID: 24799984 DOI: 10.4254/wjh.v6.i4.160]
URL: https://www.wjgnet.com/1948-5182/full/v6/i4/160.htm
Number Citing Articles
1
Masataka Izu, Yasunori Ichiki, Satoru Hashimoto, Kosei Okubo, Hiroaki Sato, Takashi Hirata, Yutaka Nagata, Takashi Kamihira. Autoimmune hepatitis with postpartum onset: a case report. Kanzo 2024; 65(2): 92 doi: 10.2957/kanzo.65.92
2
Matthias Buechter, Paul Manka, Falko Markus Heinemann, Monika Lindemann, Hideo Andreas Baba, Martin Schlattjan, Ali Canbay, Guido Gerken, Alisan Kahraman. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World Journal of Gastroenterology 2018; 24(13): 1410-1418 doi: 10.3748/wjg.v24.i13.1410
3
Juan Enciso, Ruhi Vasavada-Patel, Kyle Lien. A Rare Presentation of Drug-Induced Autoimmune Hepatitis and the Role of Male Enhancement Supplements. Cureus 2024;  doi: 10.7759/cureus.51770
4
Camilla Stephens, M. Isabel Lucena, Raúl J. Andrade. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 715 doi: 10.1002/9781119211419.ch47
5
David E. Kleiner. Histopathological challenges in suspected drug‐induced liver injury. Liver International 2018; 38(2): 198 doi: 10.1111/liv.13584
6
Igor V. Maev, Tatiana E. Polunina. Drug-induced liver injury: diagnosis of exclusion. Terapevticheskii arkhiv 2023; 95(8): 611 doi: 10.26442/00403660.2023.08.202329
7
Lucy Meunier, Jose Ursic‐Bedoya, Georges‐Philippe Pageaux, Dominique Larrey. Pantoprazole‐induced autoimmune chronic hepatitis. Liver International 2018; 38(6): 995 doi: 10.1111/liv.13737
8
Dominique Larrey, Jose Ursic‐Bedoya, Lucy Meunier. Schiff's Diseases of the Liver. 2017; : 740 doi: 10.1002/9781119251316.ch27
9
Ruizhi Gu, Alina Liang, Grace Liao, Isabelle To, Amina Shehu, Xiaochao Ma. Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond. Drug Metabolism and Disposition 2022; 50(5): 646 doi: 10.1124/dmd.121.000457
10
Nikolaos K Gatselis, Kalliopi Zachou, George K Koukoulis, George N Dalekos. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World Journal of Gastroenterology 2015; 21(1): 60-83 doi: 10.3748/wjg.v21.i1.60
11
Omar Yesid Martínez‐Casas, Gabriel Sebastián Díaz‐Ramírez, Juan Ignacio Marín‐Zuluaga, Octavio Muñoz‐Maya, Oscar Santos, Jorge Hernando Donado‐Gómez, Juan Carlos Restrepo‐Gutiérrez. Differential characteristics in drug‐induced autoimmune hepatitis. JGH Open 2018; 2(3): 97 doi: 10.1002/jgh3.12054
12
Einar S. Björnsson, Guruprasad Padur Aithal. Liver Immunology. 2020; : 491 doi: 10.1007/978-3-030-51709-0_30
13
Liping Guo, Lu Zhou, Na Zhang, Baoru Deng, Bangmao Wang. Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/2376231
14
Camilla Stephens, Agustin Castiella, Eva M. Gomez-Moreno, Pedro Otazua, Miguel-Ángel López-Nevot, Eva Zapata, Aida Ortega-Alonso, Francisco Ruiz-Cabello, Inmaculada Medina-Cáliz, Mercedes Robles-Díaz, German Soriano, Eva Roman, Hacibe Hallal, José M. Moreno-Planas, Martin Prieto, Raúl J. Andrade, M. Isabel Lucena. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis. Pharmacogenetics and Genomics 2016; 26(9): 414 doi: 10.1097/FPC.0000000000000230
15
Mark I. Avigan, Monica A. Muñoz. Drug-Induced Liver Toxicity. Methods in Pharmacology and Toxicology 2018; : 367 doi: 10.1007/978-1-4939-7677-5_18
16
Manuel Tufoni, Carmen Serena Ricci, Giacomo Zaccherini. A Case of Immune‐Mediated Liver Injury Induced by Olaparib. Hepatology 2018; 68(5): 2039 doi: 10.1002/hep.30119
17
Ynto S. de Boer, Andrzej S. Kosinski, Thomas J. Urban, Zhen Zhao, Nanye Long, Naga Chalasani, David E. Kleiner, Jay H. Hoofnagle. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clinical Gastroenterology and Hepatology 2017; 15(1): 103 doi: 10.1016/j.cgh.2016.05.043
18
Greta Codoni, Theresa Kirchner, Bastian Engel, Alejandra Maria Villamil, Cumali Efe, Albert Friedrich Stättermayer, Jan Philipp Weltzsch, Marcial Sebode, Christine Bernsmeier, Ana Lleo, Tom JG. Gevers, Limas Kupčinskas, Agustin Castiella, Jose Pinazo, Eleonora De Martin, Ingrid Bobis, Thomas Damgaard Sandahl, Federica Pedica, Federica Invernizzi, Paolo Del Poggio, Tony Bruns, Mirjam Kolev, Nasser Semmo, Fernando Bessone, Baptiste Giguet, Guido Poggi, Masayuki Ueno, Helena Jang, Gülsüm Özlem Elpek, Neşe Karadağ Soylu, Andreas Cerny, Heiner Wedemeyer, Diego Vergani, Giorgina Mieli-Vergani, M. Isabel Lucena, Raul J. Andrade, Yoh Zen, Richard Taubert, Benedetta Terziroli Beretta-Piccoli. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Reports 2023; 5(1): 100605 doi: 10.1016/j.jhepr.2022.100605
19
Yi Dong, Andrej Potthoff, Christoph Klinger, Ana Paula Barreiros, Dariusz Pietrawski, Christoph F Dietrich. Ultrasound findings in autoimmune hepatitis. World Journal of Gastroenterology 2018; 24(15): 1583-1590 doi: 10.3748/wjg.v24.i15.1583
20
Martin Reike‐Kunze, Roman Zenouzi, Johannes Hartel, Till Krech, Sören Weidemann, Martina Sterneck, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm, Marcial Sebode. Drug‐induced liver injury at a tertiary care centre in Germany: Model for end‐stage liver disease is the best predictor of outcome. Liver International 2021; 41(10): 2383 doi: 10.1111/liv.14985
21
Hiraku Kokubu, Yudai Tsukamoto, Toshifumi Takahashi, Yoshinao Muro, Noriki Fujimoto. Limited cutaneous systemic sclerosis with myositis showing drug‐induced liver injury and thrombotic microangiopathy. International Journal of Rheumatic Diseases 2023; 26(7): 1395 doi: 10.1111/1756-185X.14610
22
Jonathan Tse, Sam Natla, Rohit Mekala, Ian Crumm, Melissa H Olken. Atorvastatin-Induced Autoimmune Hepatitis: A Case Report. Cureus 2023;  doi: 10.7759/cureus.47807
23
Zhenyun Lin, Binbin Zhu, Xiuming Jin. Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting. Medicine 2018; 97(11): e0104 doi: 10.1097/MD.0000000000010104
24
Mara Sánchez, Agustin Castiella, Eva Zapata, Leire Zubiaurre, Josu Pérez-Yeboles, Leire Mendibil, Arantxa Iribarren. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterología y Hepatología 2018; 41(5): 311 doi: 10.1016/j.gastrohep.2017.05.010
25
Kenichi Harada. Pathology of acute hepatitis phase in autoimmune hepatitis. Kanzo 2018; 59(9): 455 doi: 10.2957/kanzo.59.455
26
Camilla Stephens, Raúl J. Andrade. Genetic Predisposition to Drug-Induced Liver Injury. Clinics in Liver Disease 2020; 24(1): 11 doi: 10.1016/j.cld.2019.08.003
27
Ailsa Gemmell, Andrew Fraser, Karin Oien, John Paul Seenan. Drug-induced liver injury with autoimmune features secondary to infliximab for ulcerative colitis. BMJ Case Reports 2023; 16(10): e254272 doi: 10.1136/bcr-2022-254272
28
Jeremy Hassoun, Nicolas Goossens, Sophie Restellini, Lucas Ramer, Marie Ongaro, Emiliano Giostra, Antoine Hadengue, Laura Rubbia‐Brandt, Laurent Spahr. Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study. JGH Open 2023; 7(2): 135 doi: 10.1002/jgh3.12862
29
Anwita Sinha, Shekhar Neema, Manish Manrai, Biju Vasudevan, S Radhakrishnan. Drug-induced liver injury: What a dermatologist should know?. Indian Journal of Drugs in Dermatology 2021; 7(2): 106 doi: 10.4103/ijdd.ijdd_53_20
30
Maria Fernanda Garcia Gonzalez, Paulo Cesar Marroquín Mijangos , Joselyn Aracely Alvarez-Meza. Hepatitis de tipo autoinmune inducida por nitrofurantoina: Un reporte de caso. Revista de la Facultad de Medicina 2024; 2(2): 60 doi: 10.37345/23045329.v2i2.121
31
Yue Wu, Jieqiang Zhu, Peter Fu, Weida Tong, Huixiao Hong, Minjun Chen. Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose. International Journal of Environmental Research and Public Health 2021; 18(13): 7139 doi: 10.3390/ijerph18137139
32
Jieqiang Zhu, Minjun Chen, Jürgen Borlak, Weida Tong. The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis. Archives of Toxicology 2020; 94(1): 273 doi: 10.1007/s00204-019-02621-4
33
Nora V. Bergasa. Clinical Cases in Hepatology. 2022; : 411 doi: 10.1007/978-1-4471-4715-2_14
34
Ignasi Olivas, Sergio Rodríguez-Tajes, Maria Carlota Londoño. Hepatitis autoinmune: retos y novedades. Medicina Clínica 2022; 159(6): 289 doi: 10.1016/j.medcli.2022.04.004
35
Marian A. Ackun-Farmmer, Christopher M. Jewell. Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity. Advanced NanoBiomed Research 2023; 3(3) doi: 10.1002/anbr.202200135
36
G.V. Volynets, A.V. Nikitin, T.A. Skvortsova, V.S. Kokiashvili. Drug-induced autoimmune-like hepatitis. Russian Journal of Evidence-Based Gastroenterology 2024; 13(1): 58 doi: 10.17116/dokgastro20241301158
37
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021; : 135 doi: 10.1016/B978-0-12-820239-5.00012-7
38
Aparna Das, Luis A. Guarda, Luis G. Allen. Liver Injury Associated With Quetiapine. Journal of Clinical Psychopharmacology 2017; 37(5): 623 doi: 10.1097/JCP.0000000000000749
39
Ignasi Olivas, Sergio Rodriguez-Tajes, Maria Carlota Londoño. Autoimmune hepatitis: Challenges and novelties. Medicina Clínica (English Edition) 2022; 159(6): 289 doi: 10.1016/j.medcle.2022.08.008
40
Shurouq H. Alqrinawi, Nuralhuda Akbar, Hind AlFaddag, Shahrazad Akbar, Lujayn Akbar, Sohail A. Butt, Mohammed Aljawad. Menotrophin Induced Autoimmune Hepatitis. Case Reports in Gastrointestinal Medicine 2019; 2019: 1 doi: 10.1155/2019/7343805
41
Andreas Benesic, Alexandra Leitl, Alexander L Gerbes. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Gut 2016; 65(9): 1555 doi: 10.1136/gutjnl-2015-309528
42
Nimish Thakral, Venkata Rajesh Konjeti, Fady William Salama. Drug induced autoimmune hepatitis: An unfortunate case of herbal toxicity from Skullcap supplement: A case report. World Journal of Hepatology 2023; 15(12): 1333-1337 doi: 10.4254/wjh.v15.i12.1333
43
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 2021; 15(2): 223 doi: 10.1007/s12072-021-10170-1
44
Emanuel Raschi, Fabrizio De Ponti. Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World Journal of Hepatology 2015; 7(13): 1761-1771 doi: 10.4254/wjh.v7.i13.1761
45
Rita Magalhães, Margarida Fonseca, Ilídio Brandão, Sofia Caridade. Autoimmune hepatitis unmasked by nimesulide. BMJ Case Reports 2016; : bcr2015212884 doi: 10.1136/bcr-2015-212884
46
Ioannis P. Trontzas, Konstantinos G. Kyriakoulis, Ioannis A. Vathiotis, Alexandros Syrigos, Georgios Kounadis, Sofia Siasiakou, Garyphalia Poulakou. Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?. Vaccines 2022; 10(12): 2073 doi: 10.3390/vaccines10122073
47
Giovanni Covini, Elena Bredi, Salvatore Badalamenti, Massimo Roncalli, Alessio Aghemo, Massimo Colombo. Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report. Hepatology Communications 2018; 2(10): 1179 doi: 10.1002/hep4.1248
48
Akash Mathavan, Akshay Mathavan, Urszula Krekora, Karen Daily. Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAM. BMJ Case Reports 2023; 16(5): e251852 doi: 10.1136/bcr-2022-251852
49
Miren García‐Cortés, Aida Ortega‐Alonso, Gonzalo Matilla‐Cabello, Inmaculada Medina‐Cáliz, Agustín Castiella, Isabel Conde, Elvira Bonilla‐Toyos, José Pinazo‐Bandera, Nelia Hernández, Martin Tagle, Vinicius Nunes, Raymundo Parana, Fernando Bessone, Neil Kaplowitz, M. Isabel Lucena, Ismael Alvarez‐Alvarez, Mercedes Robles‐Díaz, Raúl J. Andrade. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver International 2023; 43(8): 1749 doi: 10.1111/liv.15623
50
Ben L. Da, Gil Ben-Yakov, David Kleiner, Christopher Koh. Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management. Current Hepatology Reports 2018; 17(3): 235 doi: 10.1007/s11901-018-0407-9
51
Hiromasa Ohira. Current status and issues of autoimmune hepatitis in Japan. Kanzo 2015; 56(5): 167 doi: 10.2957/kanzo.56.167
52
Yassmin Hegazy, Page Axley, Goo Lee, Meagan Gray. Levetiracetam Liver Injury: A Benign Antiepileptic Agent?. ACG Case Reports Journal 2023; 10(3): e01003 doi: 10.14309/crj.0000000000001003
53
Shurouq H Alqrinawi, Nuralhuda Akbar, Hind Al Faddag, Shahrazad Akbar, Lujayn Akbar, Sohail A, Mohammed Aljawad. Menotrophin induced autoimmune hepatitis: a case report. Gastroenterology & Hepatology: Open Access 2019; 10(3): 164 doi: 10.15406/ghoa.2019.10.00376
54
Aida Ortega-Alonso, Camilla Stephens, M. Lucena, Raúl Andrade. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. International Journal of Molecular Sciences 2016; 17(5): 714 doi: 10.3390/ijms17050714
55
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020; 72(2): 671 doi: 10.1002/hep.31065
56
Chin Kimg Tan, Danielle Ho, Lai Mun Wang, Rahul Kumar. Drug-induced autoimmune hepatitis: A minireview. World Journal of Gastroenterology 2022; 28(24): 2654-2666 doi: 10.3748/wjg.v28.i24.2654
57
Mussarat N. Rahim, Rosa Miquel, Michael A. Heneghan. Approach to the patient with acute severe autoimmune hepatitis. JHEP Reports 2020; 2(6): 100149 doi: 10.1016/j.jhepr.2020.100149
58
Paul A. Schmeltzer. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 151 doi: 10.1007/978-3-030-33628-8_11
59
Elisa Bernasconi, Matteo Biagi, Stefania Di Agostino, Carmela Cursaro, Cristina Felicani, Enrico Ronconi, Elena Franchi, Arianna Carmen Costanzo, Filippo Gabrielli, Alessia Cavicchioli, Giuseppe Ienopoli, Paolo Marenghi, Alessandra Bartoli, Beatrice Serra, Davide Scalabrini, Pamela Sighinolfi, Pietro Andreone. Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series. Biomedicines 2023; 11(10): 2848 doi: 10.3390/biomedicines11102848
60
Annarosa Floreani, Paula Restrepo-Jiménez, Maria Francesca Secchi, Sara De Martin, Patrick S.C. Leung, Edward Krawitt, Christopher L. Bowlus, M. Eric Gershwin, Juan-Manuel Anaya. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2018; 95: 133 doi: 10.1016/j.jaut.2018.10.020
61
Sara Seife Hassen, Fateen Ata, Ammara Bint I Bilal, Mohamed Salih Ali, Mahir Petkar, Abdelnaser Y. Awad Elzouki, Muhammad Zahid. Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report. Clinical Case Reports 2020; 8(12): 3420 doi: 10.1002/ccr3.3421
62
Maria Adriana Rangel, Isabel Pinto Pais, Raquel Duarte, Isabel Carvalho. Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges. Case Reports in Pediatrics 2017; 2017: 1 doi: 10.1155/2017/5741896
63
Non-Neoplastic Diseases of the Liver. 2022; : 237 doi: 10.55418/9781933477183-8
64
Karina Aivazian, Georgina V. Long, Elizabeth C. Sinclair, James G. Kench, Catriona A. McKenzie. Histopathology of pembrolizumab-induced hepatitis: a case report. Pathology 2017; 49(7): 789 doi: 10.1016/j.pathol.2017.07.010
65
Jawaher J. Alotaibi, Bushra Albuqami, Wadha Alotaibi, Rawan M. Al Ghamdi, Mohammed Alaskar, Hadi Kuriry, Nasser Almasri. Denosumab‐induced autoimmune hepatitis: Case report. Clinical Case Reports 2024; 12(4) doi: 10.1002/ccr3.8736
66
Javier Almeida, Nuria Solà-Valls, Elisa Pose, Yolanda Blanco, María Sepúlveda, Sara Llufriu, Pere Gines, Albert Saiz. Liver injury and glatiramer acetate, an uncommon association: case report and literature review. Therapeutic Advances in Neurological Disorders 2017; 10(11): 367 doi: 10.1177/1756285617722352
67
Mohammad Alshelleh, Jennifer Park, Veena John, Arvind Rishi, David Bernstein, Nitzan Roth. Olaparib-Induced Immune-Mediated Liver Injury. ACG Case Reports Journal 2022; 9(1): e00735 doi: 10.14309/crj.0000000000000735
68
Akshaya Ramachandran, Drashti Antala , Prasun Pudasainee, Sreelakshmi Panginikkod, Harsh Gupta. A Plausible Association Between the Use of Elderberry and Autoimmune Hepatitis. Cureus 2022;  doi: 10.7759/cureus.24250
69
Lorna Ewart, Athanasia Apostolou, Skyler A. Briggs, Christopher V. Carman, Jake T. Chaff, Anthony R. Heng, Sushma Jadalannagari, Jeshina Janardhanan, Kyung-Jin Jang, Sannidhi R. Joshipura, Mahika M. Kadam, Marianne Kanellias, Ville J. Kujala, Gauri Kulkarni, Christopher Y. Le, Carolina Lucchesi, Dimitris V. Manatakis, Kairav K. Maniar, Meaghan E. Quinn, Joseph S. Ravan, Ann Catherine Rizos, John F. K. Sauld, Josiah D. Sliz, William Tien-Street, Dennis Ramos Trinidad, James Velez, Max Wendell, Onyi Irrechukwu, Prathap Kumar Mahalingaiah, Donald E. Ingber, Jack W. Scannell, Daniel Levner. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Communications Medicine 2022; 2(1) doi: 10.1038/s43856-022-00209-1
70
María Isabel Guzmán Ramos, Teresa Romero García, Esther Márquez Saavedra, Emilio Suárez García, Rubén Martínez Castillo. Daño hepático inducido por dronedarona. Descripción de un caso clínico. Gastroenterología y Hepatología 2018; 41(10): 636 doi: 10.1016/j.gastrohep.2017.11.013
71
Fernanda Monge-Urrea, Ericka Montijo-Barrios. Drug-induced Liver Injury in Pediatrics. Journal of Pediatric Gastroenterology & Nutrition 2022; 75(4): 391 doi: 10.1097/MPG.0000000000003535
72
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4): 971 doi: 10.1016/j.jhep.2015.06.030
73
Tom Hosack, Djamil Damry, Sujata Biswas. Drug-induced liver injury: a comprehensive review. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231163410
74
Djoni Elkady, Chiamaka L. Okorie, Blanca Estupiñan, Mitul B. Modi, Scott J. Cotler, Eden Lake. A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion. JAAD Case Reports 2023; 39: 101 doi: 10.1016/j.jdcr.2023.07.025
75
Einar S. Björnsson, Inmaculada Medina‐Caliz, Raul J. Andrade, M. Isabel Lucena. Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports. Hepatology Communications 2022; 6(8): 1895 doi: 10.1002/hep4.1959
76
Mahmoud Slim, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, M. Rosario Cabello, Fermin Mayoral-Cleries, M. Isabel Lucena, Raul J. Andrade. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Safety 2016; 39(10): 925 doi: 10.1007/s40264-016-0436-7
77
Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander Gerbes, Arie Regev, Benedetta Terziroli Beretta-Piccoli, Christoph Schramm, David E. Kleiner, Eleonora De Martin, Gerd A. Kullak-Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, Maria Carlota Londoño, Mark Avigan, Mercedes Robles-Diaz, Miren García-Cortes, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak J. Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M Isabel Lucena, Giorgina Mieli-Vergani, Diego Vergani, Einar S. Björnsson. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. Journal of Hepatology 2023; 79(3): 853 doi: 10.1016/j.jhep.2023.04.033
78
Einar S. Björnsson. Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis. Current Hepatology Reports 2017; 16(4): 265 doi: 10.1007/s11901-017-0365-7
79
Stefan Bartl, Patrick Dinkhauser, Harald Hofer. Medikamentös-toxische Leberschädigung und Immuncheckpointinhibitor-induzierte Hepatitis. Journal für Gastroenterologische und Hepatologische Erkrankungen 2021; 19(2): 34 doi: 10.1007/s41971-021-00100-1
80
G.B. John Mancini, Steven Baker, Jean Bergeron, David Fitchett, Jiri Frohlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic Ng, Glen J. Pearson, Janet Pope, A. Yashar Tashakkor. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016). Canadian Journal of Cardiology 2016; 32(7): S35 doi: 10.1016/j.cjca.2016.01.003
81
Su Xian Zhao, Qing Shan Zhang, Li Kong, Yu Guo Zhang, Rong Qi Wang, Yue Min Nan, Ling Bo Kong. Dichlorvos Induced Autoimmune Hepatitis: A Case Report and Review of Literature. Hepatitis Monthly 2015; 15(3) doi: 10.5812/hepatmon.25469
82
Juliana Hey-Hadavi, Daniel Seekins, Melissa Palmer, Denise Coffey, John Caminis, Sandzhar Abdullaev, Meenal Patwardhan, Haifa Tyler, Ritu Raheja, Ann Marie Stanley, Liliam Pineda-Salgado, David L. Bourdet, Raul J. Andrade, Paul H. Hayashi, Lara Dimick-Santos, Don C. Rockey, Alvin Estilo. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Safety 2021; 44(6): 619 doi: 10.1007/s40264-021-01051-5
83
Hao Niu, Jiayi Ma, Inmaculada Medina‐Caliz, Mercedes Robles‐Diaz, Elvira Bonilla‐Toyos, Marwan Ghabril, Mª Isabel Lucena, Ismael Alvarez‐Alvarez, Raul J. Andrade. Potential benefit and lack of serious risk from corticosteroids in drug‐induced liver injury: An international, multicentre, propensity score‐matched analysis. Alimentary Pharmacology & Therapeutics 2023; 57(8): 886 doi: 10.1111/apt.17373
84
Sonali Kochhar, David N. Assis, Cara Mack, Hector S. Izurieta, Luigi Muratori, Alma Munoz, Dale Nordenberg, Jane F. Gidudu, Erin F. Blau, John M. Vierling. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine 2024; 42(7): 1812 doi: 10.1016/j.vaccine.2024.01.021
85
Ramzi Tababi, Hela Kchir, Habiba Debbabi, Ahmed Nefzi, Haythem Yacoub, Dhouha Cherif, Hajer Hassine, Khadija Bellil, Slim Haouet, Nadia Maamouri. Autoimmune liver disease revealed by Tuberculosis treatment: report of two cases and literature review. F1000Research 2024; 13: 1270 doi: 10.12688/f1000research.157997.1
86
Marline A J van Gemeren, Peter van Wijngaarden, Michael Doukas, Robert A. de Man. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review. Scandinavian Journal of Gastroenterology 2017; 52(1): 18 doi: 10.1080/00365521.2016.1224379
87
Mara Sánchez, Agustin Castiella, Eva Zapata, Leire Zubiaurre, Josu Pérez-Yeboles, Leire Mendibil, Arantxa Iribarren. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterología y Hepatología (English Edition) 2018; 41(5): 312 doi: 10.1016/j.gastre.2018.05.015
88
Aida Ortega‐Alonso, Raúl J Andrade. Chronic liver injury induced by drugs and toxins. Journal of Digestive Diseases 2018; 19(9): 514 doi: 10.1111/1751-2980.12612
89
Raúl J. Andrade, Mercedes Robles-Diaz, Agustín Castiella. Characterizing Drug-Induced Liver Injury With Autoimmune Features. Clinical Gastroenterology and Hepatology 2016; 14(12): 1844 doi: 10.1016/j.cgh.2016.07.022
90
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Are Gender Differences Important for Autoimmune Liver Diseases?. Life 2024; 14(4): 500 doi: 10.3390/life14040500
91
Matthias Buechter, Dominik Dorn, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, Guido Gerken, Alisan Kahraman. Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center. Journal of Clinical Medicine 2023; 12(13): 4192 doi: 10.3390/jcm12134192
92
Fernando Bessone, Geraldine L. Hillotte, Natalia Ahumada, Fernanda Jaureguizahar, Anabela C. Medeot, Marcelo G. Roma. UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis. Seminars in Liver Disease 2024; 44(01): 001 doi: 10.1055/s-0044-1779520
93
Sabine Weber, Andreas Benesic, Marie-Luise Buchholtz, Isabelle Rotter, Alexander L. Gerbes. Antimitochondrial Rather than Antinuclear Antibodies Correlate with Severe Drug-Induced Liver Injury. Digestive Diseases 2021; 39(3): 275 doi: 10.1159/000511635
94
Theresa Kirchner, Björn Hartleben, Sophia Köhler, Frank Schuppert, Irina Berger, Heiner Wedemeyer, Ingmar Mederacke. Autoimmune hepatitis in young Somalian men – experience from a German tertiary care center. F1000Research 2023; 12: 178 doi: 10.12688/f1000research.127275.1
95
Melissa Palmer, Arie Regev, Keith Lindor, Mark I. Avigan, Lara Dimick‐Santos, William Treem, John F. Marcinak, James H. Lewis, Frank A. Anania, Daniel Seekins, Benjamin L. Shneider, Naga Chalasani. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics 2020; 51(1): 90 doi: 10.1111/apt.15579
96
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
97
María Isabel Guzmán Ramos, Teresa Romero García, Esther Márquez Saavedra, Emilio Suárez García, Rubén Martínez Castillo. Dronedarone-induced liver injury. A case report. Gastroenterología y Hepatología (English Edition) 2018; 41(10): 636 doi: 10.1016/j.gastre.2018.11.015
98
Ulrich Beuers, M. Eric Gershwin. Unmet Challenges in Immune-Mediated Hepatobiliary Diseases. Clinical Reviews in Allergy & Immunology 2015; 48(2-3): 127 doi: 10.1007/s12016-015-8484-9
99
Jonathan G. Stine, Patrick G. Northup. Autoimmune-like drug-induced liver injury: a review and update for the clinician. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(11): 1291 doi: 10.1080/17425255.2016.1211110
100
Alex R. Jones, Margaret Kypreos, Mark R. Pedersen. A Rare Case of Doxycycline-Induced Autoimmune Hepatitis With Organizing Pneumonia. Annals of Internal Medicine: Clinical Cases 2023; 2(9) doi: 10.7326/aimcc.2023.0375
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345